Phase 4 HIV and AIDS Trial, Recruiting NCT06514547 Sponsor: Hennepin Healthcare Research Institute Condition: HIV and AIDS
Back to Hiv Aids

Phase 4 HIV and AIDS Trial, Recruiting

NCT06514547
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people living with HIV:

  • People who are 18 years of age or older
  • People who have been diagnosed with HIV
  • People who are currently on HIV treatment (antiretroviral therapy) and whose HIV viral load (the amount of virus in the blood) has been below 200 in the past year

For people joining as a comparison/control group:

  • People who are 18 years of age or older
  • People who have tested negative for HIV

Who may not be able to join:

  • People who have another serious condition that significantly weakens the immune system
  • People who are under 18 years of age
  • People who are pregnant at the time of enrolling in the trial
  • People for whom pneumococcal (pneumonia) vaccination is not medically appropriate
  • People with severe anaemia, meaning their last haemoglobin blood test result was below 8g/dl
  • People who the trial investigator believes may have difficulty following the trial's schedules or procedures
  • People who are not able to give their own informed consent to participate
  • People who are in prison or detained at the time of enrolling in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: (612)-283-4349

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Hennepin Healthcare Research Institute
Registry
ClinicalTrials.gov
Start date
8 July 2024
Est. completion
15 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary objective

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov